2 months ago
ELF
AnalystsJoel BeattyJoel Beatty's Stock Forecasts
AnalystsJoel Beatty
Analyst Ranking
Top 25%
#1156 out of 4705 analysts
Average Return
+2.73%
Win Rate
43%49 out of 114
Risk vs Reward
Poor
Good
Joel Beatty's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cymabay Therapeutics IncCBAY | +258.57% | $1.40 | $5.02 | 2020-03-20 - 2021-03-19 | Strong Buy |
Ambrx Biopharma IncAMAM | +252.16% | $7.86 | $27.68 | 2023-04-05 - 2024-01-16 | Buy |
Novavax IncNVAX | +203.39% | $88.60 | $268.80 | 2014-08-13 - 2015-08-13 | Strong Buy |
Esperion Therapeutics IncESPR | +197.78% | $26.17 | $77.93 | 2017-02-28 - 2018-01-22 | Strong Buy |
Arena Pharmaceuticals IncARNA | +173.80% | $15.23 | $41.70 | 2017-06-27 - 2018-06-27 | Strong Buy |
Joel Beatty Analyst Color
Get additional color on Joel Beatty's coverage of popular stocks
7 months ago
AMLX
Joel Beatty's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sage Therapeutics IncSAGE | 4 | Hold | $9.00 | +36.57% | Maintains | 5 days ago |
Ptc Therapeutics IncPTCT | 7 | Buy | $44.00 | +12.82% | Reiterates | 6 days ago |
Cogent Biosciences IncCOGT | 3 | Hold | $10.00 | -11.11% | Maintains | a month ago |
Larimar Therapeutics IncLRMR | 1 | Buy | $16.00 | +128.90% | Initiates Coverage On | a month ago |
Elf Beauty IncELF | 3 | Buy | $240.00 | +118.74% | Maintains | 2 months ago |
Blueprint Medicines CorpBPMC | 2 | Buy | $127.00 | +43.00% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Buy | $154.00 | +41.54% | Maintains | 2 months ago |
Argenx SeARGX | 4 | Buy | $515.00 | -4.04% | Maintains | 3 months ago |
Dianthus Therapeutics IncDNTH | 1 | Buy | $58.00 | +110.91% | Initiates Coverage On | 3 months ago |
Alkermes PLCALKS | 2 | Buy | $38.00 | +31.44% | Maintains | 3 months ago |
Longboard Pharmaceuticals IncLBPH | 2 | Buy | $60.00 | +54.24% | Maintains | 3 months ago |
Immutep LtdIMMP | 4 | Buy | $6.00 | +191.26% | Maintains | 4 months ago |
Neurogene IncNGNE | 1 | Buy | $54.00 | +9.25% | Initiates Coverage On | 4 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Buy | $72.00 | +30.67% | Maintains | 4 months ago |
Mind Medicine IncMNMD | 1 | Buy | $27.00 | +399.08% | Initiates Coverage On | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Hold | $72.00 | +2.35% | Downgrades | 5 months ago |
Calidi Biotherapeutics IncCLDI | 3 | Buy | $20.00 | +1,786.79% | Maintains | 5 months ago |
Acadia Pharmaceuticals IncACAD | 3 | Buy | $28.00 | +87.67% | Maintains | 5 months ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $112.00 | +27.91% | Maintains | 5 months ago |
Praxis Precision Medicines IncPRAX | 1 | Buy | $117.00 | +80.00% | Initiates Coverage On | 5 months ago |
Geron CorpGERN | 2 | Hold | $4.50 | +3.93% | Downgrades | 5 months ago |
Intra Cellular Therapies IncITCI | 2 | Buy | $103.00 | +35.96% | Maintains | 6 months ago |
Nurix Therapeutics IncNRIX | 2 | Buy | $25.00 | +5.80% | Maintains | 6 months ago |
Amylyx Pharmaceuticals IncAMLX | 3 | Hold | $3.00 | -15.49% | Maintains | 6 months ago |
Leap Therapeutics IncLPTX | 2 | Buy | $9.00 | +289.61% | Maintains | 7 months ago |
Ambrx Biopharma IncAMAM | 3 | Hold | $28.00 | 0.00% | Downgrades | 9 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Buy | $28.00 | N/A | Maintains | a year ago |
Vaxxinity IncVAXX | 1 | Buy | $7.00 | N/A | Initiates Coverage On | a year ago |
Tracon Pharmaceuticals IncTCON | 3 | Buy | $60.00 | N/A | Maintains | a year ago |
Inmune Bio IncINMB | 1 | Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Chimerix IncCMRX | 1 | Buy | $7.00 | N/A | Initiates Coverage On | a year ago |
Beyondspring IncBYSI | 2 | Buy | $1.25 | N/A | Maintains | a year ago |
Pliant Therapeutics IncPLRX | 3 | Buy | $44.00 | N/A | Initiates Coverage On | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Buy | $58.00 | N/A | Maintains | 2 years ago |
Ideaya Biosciences IncIDYA | 2 | Buy | $24.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 2 | Buy | $18.00 | N/A | Maintains | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Sell | $18.00 | N/A | Downgrades | 2 years ago |
Cardiff Oncology IncCRDF | 2 | Buy | $6.00 | N/A | Maintains | 2 years ago |
Igm Biosciences IncIGMS | 2 | Buy | $31.00 | N/A | Maintains | 2 years ago |
Vir Biotechnology IncVIR | 2 | Hold | $28.00 | N/A | Upgrades | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Hold | $175.00 | N/A | Downgrades | 4 years ago |
Vanda Pharmaceuticals IncVNDA | 4 | Hold | $14.00 | N/A | Downgrades | 4 years ago |
Sarepta Therapeutics IncSRPT | 2 | Hold | $108.00 | N/A | Downgrades | 4 years ago |
Eidos Therapeutics IncEIDX | 2 | Hold | $73.26 | N/A | Downgrades | 4 years ago |
Eloxx Pharmaceuticals IncELOX | 1 | Hold | $160.00 | N/A | Downgrades | 4 years ago |
Ayala Pharmaceuticals IncAYLA | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Tempest Therapeutics IncTPST | 2 | Strong Buy | $6.00 | N/A | Reinstates | 4 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Strong Buy | $71.00 | N/A | Maintains | 5 years ago |
Phasebio Pharmaceuticals IncPHASQ | 1 | Strong Buy | $11.00 | N/A | Maintains | 5 years ago |
Dbv Technologies SaDBVT | 2 | Strong Buy | $20.00 | N/A | Maintains | 5 years ago |
Amarin Corp PLCAMRN | 3 | Strong Buy | $6.00 | N/A | Maintains | 5 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $28.00 | N/A | Maintains | 5 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $15.00 | N/A | Maintains | 5 years ago |
Cymabay Therapeutics IncCBAY | 1 | Strong Buy | $1.60 | N/A | Maintains | 5 years ago |
Esperion Therapeutics IncESPR | 5 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Intercept Pharmaceuticals IncICPT | 5 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Medicines CoMDCO | 3 | Strong Buy | $50.00 | N/A | Maintains | 6 years ago |
Atyr Pharma IncATYR | 4 | Hold | $10.50 | N/A | Upgrades | 6 years ago |
Astria Therapeutics IncATXS | 3 | Strong Buy | $1.50 | N/A | Maintains | 6 years ago |
Arena Pharmaceuticals IncARNA | 3 | Strong Buy | $55.00 | N/A | Maintains | 7 years ago |
Novavax IncNVAX | 7 | Hold | $55.00 | N/A | Maintains | 7 years ago |
Kura Oncology IncKURA | 1 | Strong Buy | $19.00 | N/A | Maintains | 7 years ago |
Dimension Therapeutics IncDMTX | 3 | Hold | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.